Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?
Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and HumanServices, Bethesda, Maryland 20892, USA.
Giacomo
G
Salvadore
Carlos A
CA
Zarate
D015415:Biomarkers / Q000378:metabolism; D016503:Drug Delivery Systems / Q000379:methods*; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008959:Models, Neurological; D019964:Mood Disorders / Q000175:diagnosis* / Q000188:drug therapy*; D057285:Precision Medicine / Q000379:methods*
D015415:Biomarkers; D018698:Glutamic Acid